# Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock

> **NCT06122987** · PHASE4 · RECRUITING · sponsor: **Kingman Regional Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Septic Shock
- Shock
- Sepsis
- Systemic Inflammatory Response Syndrome

## Interventions

- **DRUG:** Angiotensin II and hydrocortisone sodium succinate

## Key facts

- **NCT ID:** NCT06122987
- **Lead sponsor:** Kingman Regional Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-04
- **Primary completion:** 2024-12
- **Final completion:** 2025-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06122987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06122987, "Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06122987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*